Back to main page

DREAM Module Identification Challenge – Consensus modules

PPI-STRING_Consensus_mod186

Assigned name NA
Network PPI-STRING
Module ID PPI-STRING_Consensus_mod186
Module size 21 genes

Module genes

This module comprises the following genes:

Gene ID Gene Symbol Gene Name
84226

C2orf16 chromosome 2 open reading frame 16
1400

CRMP1 collapsin response mediator protein 1
51706

CYB5R1 cytochrome b5 reductase 1
51700

CYB5R2 cytochrome b5 reductase 2
1727

CYB5R3 cytochrome b5 reductase 3
51167

CYB5R4 cytochrome b5 reductase 4
606495

CYB5RL cytochrome b5 reductase like
1723

DHODH dihydroorotate dehydrogenase (quinone)
1806

DPYD dihydropyrimidine dehydrogenase
1807

DPYS dihydropyrimidinase
1808

DPYSL2 dihydropyrimidinase like 2
1809

DPYSL3 dihydropyrimidinase like 3
10570

DPYSL4 dihydropyrimidinase like 4
56896

DPYSL5 dihydropyrimidinase like 5
2232

FDXR ferredoxin reductase
83943

IMMP2L inner mitochondrial membrane peptidase subunit 2
92106

OXNAD1 oxidoreductase NAD binding domain containing 1
9963

SLC23A1 solute carrier family 23 member 1
9962

SLC23A2 solute carrier family 23 member 2
151295

SLC23A3 solute carrier family 23 member 3
7372

UMPS uridine monophosphate synthetase

Functional annotation

Modules were tested for enrichment in functional and pathway annotations using two complementary approaches:
1. To select a small number of specific / non-redundant annotations for each module, a regression-based approach was used;
2. To obtain the complete set of enriched annotations, an extension of Fisher’s exact test that takes annotation bias into account was employed (Wallenius’ non-central hypergeometric distribution).

Most specific annotations for this module

Coeff.1P-value.2Source.3Term.4Class.5
3.26e-01 3.48e-06 Reactome Pyrimidine biosynthesis

Metabolism
2.76e-01 1.16e-06 GO L-ascorbic acid transmembrane transporter activity

molecular_function
2.75e-01 1.16e-06 GO L-ascorbic acid transmembrane transport

biological_process
1.55e-01 4.05e-12 Reactome CRMPs in Sema3A signaling

Developmental Biology
8.63e-02 5.26e-10 Reactome Erythrocytes take up carbon dioxide and release oxygen

Transport of small molecules
8.57e-02 5.26e-10 Reactome O2/CO2 exchange in erythrocytes

Transport of small molecules
4.67e-02 6.40e-08 Reactome Vitamin C (ascorbate) metabolism

Metabolism
4.45e-02 3.26e-07 GO filamin binding

molecular_function
2.83e-02 3.32e-03 Reactome Electron transport from NADPH to Ferredoxin

Metabolism
2.15e-02 6.34e-05 GO pyrimidine nucleoside catabolic process

biological_process

1Regression coefficient

2Fisher’s exact test nominal P-value

3Annotation source (Reactome, GO biological process (BP), molecular function (MF) and cellular component (CC))

4GO category or Reactome pathway

5High-level branch of annotation tree

Gene membership

All enriched annotations

Gene Ontology

P-value1 FDR2 Term
8.10e-13 5.61e-10 cytochrome-b5 reductase activity, acting on NAD(P)H

2.45e-12 1.68e-09 oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor

1.94e-08 1.22e-05 pyrimidine nucleobase metabolic process

3.16e-08 1.32e-05 hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds

1.19e-07 4.51e-05 filamin binding

1.83e-07 6.71e-05 oxidoreductase activity, acting on NAD(P)H

2.23e-07 8.05e-05 oxidoreductase activity

4.68e-07 2.36e-04 bicarbonate transport

1.67e-06 7.61e-04 L-ascorbic acid metabolic process

4.99e-06 2.06e-03 pyrimidine nucleoside metabolic process

1.52e-05 5.63e-03 organic anion transport

1.91e-05 6.90e-03 uracil metabolic process

1.91e-05 6.90e-03 'de novo' UMP biosynthetic process

2.39e-05 8.40e-03 'de novo' pyrimidine nucleobase biosynthetic process

2.85e-05 6.81e-03 hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides

2.90e-05 9.97e-03 sterol metabolic process

2.98e-05 1.02e-02 thymine metabolic process

2.98e-05 1.02e-02 thymine catabolic process

2.98e-05 1.02e-02 pyrimidine nucleobase catabolic process

3.39e-05 1.14e-02 steroid biosynthetic process


11Nominal enrichment p-value (Wallenius’ noncentral hypergeometric distribution)

2FDR corrected p-value (Benjamini-Hochberg)

Reactome

P-value1 FDR2 Term
3.06e-11 1.15e-08 CRMPS IN SEMA3A SIGNALING
1.06e-10 2.89e-08 CRMPS IN SEMA3A SIGNALING
8.30e-09 2.46e-06 SEMAPHORIN INTERACTIONS
7.37e-08 1.46e-05 SEMAPHORIN INTERACTIONS
2.41e-07 5.94e-05 PYRIMIDINE METABOLISM
3.33e-07 6.15e-05 PYRIMIDINE METABOLISM
9.21e-06 1.77e-03 AXON GUIDANCE
2.87e-05 5.05e-03 METABOLISM OF NUCLEOTIDES
4.18e-05 5.68e-03 AXON GUIDANCE
5.41e-05 7.24e-03 METABOLISM OF NUCLEOTIDES
1.05e-04 1.62e-02 METABOLISM OF VITAMINS AND COFACTORS
1.34e-04 2.02e-02 DEVELOPMENTAL BIOLOGY
3.15e-04 4.29e-02 PYRIMIDINE CATABOLISM
6.71e-04 7.04e-02 METABOLISM OF VITAMINS AND COFACTORS
8.49e-04 8.68e-02 PYRIMIDINE CATABOLISM
1.85e-02 1.00e+00 RECYCLING PATHWAY OF L1
2.21e-02 1.00e+00 RECYCLING PATHWAY OF L1

11Nominal enrichment p-value (Wallenius’ noncentral hypergeometric distribution)

2FDR corrected p-value (Benjamini-Hochberg)

Mouse mutant phenotypes

P-value1 FDR2 Term
1.96e-05 7.47e-02 abnormal vitamin C level

3.30e-04 4.74e-01 abnormal hippocampus pyramidal cell morphology

1.87e-03 1.00e+00 abnormal adrenocortical cell morphology

1.87e-03 1.00e+00 abnormal gland physiology

5.32e-03 1.00e+00 abnormal dopamine level

5.61e-03 1.00e+00 abnormal penile erection

5.61e-03 1.00e+00 abnormal vitamin absorption

5.62e-03 1.00e+00 hyperlipidemia

7.47e-03 1.00e+00 abnormal renal filtration rate

9.36e-03 1.00e+00 impaired synaptic plasticity

9.36e-03 1.00e+00 decreased circulating corticosterone level

1.09e-02 1.00e+00 abnormal Purkinje cell dendrite morphology

1.12e-02 1.00e+00 absent long term depression

1.12e-02 1.00e+00 decreased pancreatic beta cell number

1.12e-02 1.00e+00 abnormal adrenal gland secretion

1.30e-02 1.00e+00 abnormal adrenaline level

1.31e-02 1.00e+00 abnormal hippocampus CA1 region morphology

1.68e-02 1.00e+00 abnormal hippocampus pyramidal cell layer

2.23e-02 1.00e+00 absent mature ovarian follicles

2.41e-02 1.00e+00 aminoaciduria


11Nominal enrichment p-value (Wallenius’ noncentral hypergeometric distribution)

2FDR corrected p-value (Benjamini-Hochberg)


Generated on: Thu Aug 30 17:28:59 2018 - R2HTML